Wusu, Tacheng Prefecture, Xinjiang, China admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:



Pefloxacin Mesylate: From Historical Milestones to Future Frontiers

Historical Development

Every family medicine cabinet tells a story. When I notice names like Pefloxacin Mesylate in medical journals or on product labels, I’m reminded of how pharmaceutical innovation builds on decades of research and the real-world need for fast, reliable solutions against infection. Pefloxacin emerged as a fluoroquinolone antibiotic in the late 1970s, during a time when bacteria were beginning to outwit older treatments like penicillin and tetracyclines. Researchers, determined to tip the balance back in favor of effective care, went through rounds of chemical refinement and clinical trials. By the 1980s, French laboratories, notably Rhône-Poulenc, introduced it for hospital and veterinary use. Global acceptance didn’t happen overnight, since early concerns around resistance and toxicity followed most new antibiotics, yet practitioners quickly recognized the broad-spectrum punch it delivered against both Gram-negative and Gram-positive pathogens.

Product Overview

At its core, Pefloxacin Mesylate offers robust antibacterial action. This medication gets prescribed for urinary tract infections, gastrointestinal diseases, and bone infections, among other uses. A bottle on the pharmacy shelf often holds white or yellow-tinged powder, sometimes as tablets or injectable solutions. Healthcare workers rely on its quick absorption, decent bioavailability, and ability to tackle challenging infections where traditional options fall short. Patients who’ve struggled with recurring UTIs or post-surgical infections may have relied on its quick intervention at some point.

Physical & Chemical Properties

Taking a closer look at Pefloxacin Mesylate in the lab, you’ll notice a crystalline substance with solid thermal stability up to moderate temperatures. Its chemical formula, C17H20FN3O4·CH4O3S, hints at complexity. The molecule absorbs ultraviolet rays—important for monitoring drug levels in the blood or urine during hospital treatment. Pefloxacin’s solubility in water and ethanol makes it practical for injectable and oral forms. It’s got a strong, almost unyielding bitterness; that chemical taste lingers, which is one reason coated tablets landed on the market. Its melting point stands between 220–230°C, making accidental decomposition unlikely, and its stable shelf life brings confidence to clinics storing antibiotics in bulk.

Technical Specifications & Labeling

Regulatory agencies like the FDA and EMA lay out strict standards for purity, assay, and labeling. For clinics and pharmacies, labels flag crucial details: batch numbers, expiry dates, and specific dosing recommendations based on age, weight, and renal function. Each unit gets tested for contaminants and heavy metals, with specifications often calling for at least 98% active ingredient by weight. In my years navigating medication procurement, labels with strong batch traceability proved vital; hospitals who didn’t guard these records sometimes faced shortages or quality questions during audits. Safe handling guidelines often accompany large shipments, reminding workers of protective equipment to use during compounding or dose preparation.

Preparation Method

In terms of synthesis, preparing Pefloxacin Mesylate combines modern organic chemistry with pharmaceutical standardization. The creation begins with condensation of piperazine and quinolone intermediates, often under dry conditions and inert atmosphere, before methylsulfonic acid introduces the mesylate salt. Reaction vessels stay tightly controlled under moderate pressure and heat. Purification gets handled by repeated filtration and recrystallization with ethanol or water, yielding powder that’s easy to press into tablets or dissolve for injection. Bulk drug manufacturers test samples after synthesis, confirming molecular structure through spectrometry and liquid chromatography analysis.

Chemical Reactions & Modifications

Experimentation with related compounds led chemists to explore tweaks to the base structure. Medicinal chemists tried attaching different side chains to the quinolone ring to produce variations that absorbed better, resisted bacterial enzymes, or triggered fewer side effects. Pefloxacin’s strong core chemotype, with its fluorine-forged backbone, blocks bacterial DNA gyrase—the very mechanism bacteria need to duplicate genetic material. Over the years, its structure served as a template for future fluoroquinolone candidates, with minor alterations changing everything from spectrum of activity to half-life in the body.

Synonyms & Product Names

Pharmaceutical trade rolls out plenty of aliases. Pharmacy shelves may list this agent as Belox, Peflox, Peflacin, or simply Pefloxacin. Sometimes packages refer to it as Pefloxacinum or its full salt name, Pefloxacin Mesylate, for clarity. Context matters: human medicine, veterinary products, and research chemicals often come under different brand labels, prompting prescribers and suppliers to double-check before filling orders. This web of trade names sometimes confuses new clinicians, but manufacturers stick to strict regulatory guidelines to limit mix-ups.

Safety & Operational Standards

Healthcare teams don’t take antibiotics lightly. As with all fluoroquinolones, Pefloxacin comes with specific safety protocols. Adverse reactions like tendon swelling, photosensitivity, or even rare psychiatric symptoms get flagged in patient monitoring forms. Staff receive regular training on allergic reaction triage and watch for signs of drug-induced arrhythmias or liver changes. Regular quality audits ensure manufacturing lines avoid cross-contamination with other antibiotics, and waste handling gets tracked to keep environmental exposure low. On more than one hospital round, I’ve watched pharmacy techs double-check every syringe and pill, especially when dealing with high-risk populations like kids or the elderly.

Application Area

Doctors and veterinarians turn to Pefloxacin in tough cases. Beyond stubborn UTIs, it treats osteomyelitis, prostatitis, and infections in neutropenic patients. Surgeons sometimes prescribe it after orthopedic procedures to stave off bone infections. Veterinary clinics use it for serious respiratory or digestive infections in dogs, cats, and livestock. A few industrial applications appear in the testing of antimicrobial surfaces or water purification research, though these remain niche uses. Hospitals treating immunocompromised patients trust it as an option when other antibiotics fail or resistance patterns limit choices.

Research & Development

Pefloxacin has inspired years of research in both academic and industrial labs. Scientists keep studying its action against new bacterial strains and evaluating different delivery methods—extended-release forms, for instance, or combo therapies with beta-lactam antibiotics to tackle resistance. Recent research points to rising resistance among Enterobacteriaceae and Pseudomonas aeruginosa, reminding medical teams of the importance of stewardship. Studies probing the drug’s pharmacokinetic and pharmacodynamic profile in aged or renally impaired patients keep rolling out. Universities explore the potential for new derivatives: tweaking the quinolone backbone for more selective targeting or less toxicity.

Toxicity Research

Toxicology shaped the reputation of Pefloxacin almost as much as its successes. Early reports noted risks for cartilage damage in growing children, rare but serious nerve complications, and mitochondrial toxicity under unusual circumstances. Animal models detected altered spinal growth at high doses, which led regulators to restrict pediatric and prenatal use. Reports from France, India, and several other countries detail both the positive and negative sides: quick recovery in most adults balanced against rare tendon ruptures or neuropsychiatric events. Regulatory bodies watch outcomes closely, updating dosing guidance and safety alerts based on new evidence and real-world surveillance.

Future Prospects

Medical science doesn’t sit still. While resistance pressures have shifted clinical use away from routine prescribing in some places, Pefloxacin continues to play a role in hospital protocols, especially where multidrug-resistant bacteria demand broader options. Drug developers remain interested in next-generation fluoroquinolones, mining the lessons learned from Pefloxacin’s long history. Improved diagnostic tools may open a future where high-powered antibiotics target only confirmed pathogens, cutting down misuse and resistance. Patient genetics now get a closer look, helping doctors avoid adverse reactions by matching medications to individual profiles. Polishing up the quinolone formula for better tissue penetration, reduced toxicity, or combination therapies could extend the shelf life of this venerable class. As health systems chase the next breakthrough in infection control, stories like Pefloxacin’s remind us how much thoughtful chemistry, paired with on-the-ground vigilance, matters in both patient care and public health.




What is Pefloxacin Mesylate used for?

A Doctor’s Perspective on Treating Infections

Bacterial infections show up in everyday life more often than people expect. You catch a fever, get a wound that turns warm and swollen, or struggle with burning urination. In these moments, the right antibiotic means everything. Pefloxacin mesylate stands as one option doctors trust for specific infections. Having seen hospital wards and spoken with pharmacists about treatment plans, it’s easy to spot how important this drug can be.

Where Pefloxacin Mesylate Fits in the Hospital

Pefloxacin mesylate belongs to a group called fluoroquinolones. Physicians often bring it out for urinary tract infections, certain prostate infections, and a handful of hospital-acquired bugs. Some patients deal with complicated infections that standard antibiotics can’t seem to handle. In my time working with infectious disease teams, I learned that pefloxacin sometimes enters the picture after older drugs fail.

Urinary tract infections, especially in patients with catheters or chronic health problems, often respond better to this medicine than older drugs. Pelvic and gynecological infections also respond in cases where other treatments have stumbled. Some surgeons prefer this drug as a backup for infections in bones and joints, too. Doctors in parts of Africa and Asia, where pefloxacin is more available, rely on it more than in the United States or Europe, but the science behind its use remains strong everywhere.

Not the First Line, But Sometimes the Only Option

Years of watching antibiotic resistance rise have changed the way hospitals use broad-spectrum drugs like pefloxacin. Overuse leads bacteria to adapt. That’s why infectious disease doctors save it for moments when other pills or shots can’t clear the infection. If a patient reacts to penicillin, or if lab testing shows a bug ignores common antibiotics, switching to pefloxacin often brings results.

A friend working in a busy emergency room once told me about a diabetic patient with a deep foot infection that resisted regular therapies. Swapping to pefloxacin after checking bacterial cultures cleared the infection without amputation. For that patient, access to the right drug made the difference between healing and a lifetime injury.

Balancing Power and Risk

No medicine comes free of side effects. Fluoroquinolones like pefloxacin carry warnings about tendon ruptures, nerve pain, and mental status changes, especially in older adults. I’ve seen patients develop unexpected soreness in their calves or report dizziness after starting this drug. Pharmacists and doctors guide patients to watch for these problems and report anything strange right away. Using this antibiotic wisely avoids dangerous outcomes and makes sure it stays useful for patients who truly need it.

Putting Guidelines Into Practice

Public health agencies recommend reserving pefloxacin for infections that resist simpler treatments. Hospitals set up antibiotic stewardship programs that track prescriptions closely. I’ve helped draft these protocols, and I know how much discussion goes into every line. Doctors and pharmacists check local resistance patterns, keep up with new research, and make changes if bacteria develop resistance in their region. This team approach means patients get the best shot at a real recovery, without wasting future options.

Looking at the Big Picture

In the end, pefloxacin mesylate stands as a crucial tool in fighting resistant bacteria. People need to trust their healthcare teams to pick the safest, most effective path based on test results and individual history. Doctors weigh the risk of serious infection against possible side effects, balancing experience and evidence to make every dose count. That’s what turns a prescription into a life-saving choice.

What are the possible side effects of Pefloxacin Mesylate?

Understanding the Scope of Side Effects

Nobody really wants to talk about side effects unless they're strong enough to disrupt daily life. Pefloxacin Mesylate, widely used to tackle bacterial infections, doesn’t get discussed as often as drugs like ciprofloxacin, but it comes from the same class – fluoroquinolones. With strong antibiotics like these, the relief from infection often comes with a few trade-offs.

Common Bodily Reactions

Nausea gets most people first. I’ve spoken with a handful who shared stories about feeling queasy or battling stomach upset after starting pefloxacin. Some folks end up dealing with diarrhea and, less commonly, vomiting. Doctors see it often enough that they’ll warn patients to eat before taking the capsule or at least stick with plenty of water. Gut problems seem like a small price to pay if the infection’s tough, but these reactions sometimes have folks questioning if it’s worth finishing the course.

Tendons and Joints: The Unwanted Surprise

Some side effects go beyond just feeling sick to your stomach. Pefloxacin, like other fluoroquinolones, can cause tendinitis or even tendon rupture in rare cases. I remember a neighbor, an active runner, tearing his Achilles tendon after a short course of antibiotics; doctors pointed to the pills. The risk jumps for those over 60, or anyone taking steroids for other reasons. Physical activity sometimes amplifies these risks, so people with joint pain during treatment should check in with their healthcare provider, not just push through.

Central Nervous System: Unusual Experiences

Occasional tales of sleeplessness or intense nightmares aren’t just exaggeration. Some have described confusion, restlessness, or tremors while using pefloxacin. Children seem especially vulnerable to these effects, and older adults sometimes get more disoriented than expected. One night of lost sleep is one thing, but repeated neurological symptoms shouldn’t be dismissed as just “part of being sick.” Some people find these experiences more troubling than the infection itself.

Allergic Reactions and Skin Concerns

Allergic reactions deserve respect. People can break out in rashes or hives, and, in truly rare cases, things get serious fast – think swelling or trouble breathing. Those who already have allergies need to bring these up with doctors before starting new medication. I’ve seen friends end up in the ER just from assuming an itchy rash would pass.

Potential Solutions and Practical Steps

Each body responds in its own way. To lower risk, start by sharing a thorough health history with your doctor. Mention any previous trouble with antibiotics and flag any signs of tendon pain or neurological changes straight away. If gut issues make life miserable, probiotics or changes to diet help some people keep food down. For tendon pain, there’s no shame in pausing activity and calling a medical provider. Skipping doses or quitting early can feed resistance and make future infections tougher to treat, so honest conversation always helps.

With antibiotics like pefloxacin, weighing the benefit against possible side effects keeps things real. Listen to your body, speak up when things feel off, and remember that sharing experiences helps everyone involved – not just the doctor, but the next person who googles their symptoms in a panic late at night.

How should Pefloxacin Mesylate be taken or administered?

Understanding the Basics

Pefloxacin Mesylate belongs to the fluoroquinolone class of antibiotics. It’s used to tackle a range of bacterial infections, and doctors often turn to it when more common drugs aren’t getting the job done. It acts by stopping the bacteria from multiplying, helping the body’s immune system wipe out the infection for good.

Getting the Dose Right

Many folks don’t give much thought to timing or dosage for antibiotics, but skipping doses or making up your own schedule crops up more than anyone would like to admit. From years covering public health, skipping pills or ending a course early barely lets the medicine work. It’s not just about not feeling better, either. This habit can invite bacteria to outsmart the very drugs made to kill them. Pefloxacin Mesylate isn’t special in this regard, but it relies on a steady level in your bloodstream. Taken with a full glass of water, and often prescribed twice a day, meals don’t matter unless your doctor tells you otherwise. Some folks feel less stomach upset when taking it with food, though. Oddly enough, dairy products like milk, cheese, and yogurt block the body from absorbing it like it should. So, spacing those out by a couple of hours makes all the difference.

Staying Safe: Side Effects and Drug Interactions

Most antibiotics get shrugged off as harmless, but it pays to check the fine print. Like its cousins in the same class, Pefloxacin Mesylate sometimes leads to tendon pain, swelling, or even a tear. That risk shoots up if someone is older, already on steroids, or has kidney problems. Some people notice sensitive skin or wild swings in mood. Mixing Pefloxacin Mesylate with caffeine or non-steroidal painkillers can make jitters or nervousness worse. Some blood thinners, diabetes meds, and other antibiotics tangle up with it too, which sometimes makes standard health complaints spiral out of control. Pharmacists and doctors need to check the whole list of drugs and supplements a patient uses—over-the-counter stuff included.

The Power of Finishing the Course

Stopping an antibiotic course early used to seem harmless, especially once fever and aches faded. Through talking with countless patients, many doctors now spend extra time explaining that even if symptoms disappear, bacteria might not be wiped out. A lingering infection can bounce back, send someone to the hospital, or spread bugs toughened by half-baked treatment. A complete course, even when the bottle’s almost empty and energy’s back, closes the door on resistant germs that could find new hosts.

Practical Reminders and Real-World Solutions

Written instructions help, but real life doesn’t always stick to plans. Forgetfulness and confusion around taking pills at regular times happen for everyone, young and old. Simple tools—setting phone alarms or using a pillbox—keep things on track. For some, getting a friend or relative to ask about missed doses does more than a calendar note. In crowded clinics, teaching people how drugs interact or sharing stories of why skipping antibiotics backfired gives the message stronger impact than just listing side effects. Communication beats paperwork every time.

Closing Gaps in Knowledge

Many infections cleared by Pefloxacin Mesylate don’t make news. Most recover fully, work returns, and life rolls on. Still, drug resistance and avoidable complications are real headaches for public health. By sharing how to take antibiotics wisely, double-checking drug interactions, and sticking to advice from trusted health workers, patients get stronger results—and communities see fewer dangerous strains spreading among them.

Are there any precautions or contraindications for Pefloxacin Mesylate?

What Makes Pefloxacin Different

Pefloxacin mesylate falls under the family of fluoroquinolone antibiotics. Doctors sometimes use it in tough situations, such as when infections push back against other antibiotics. The strength of pefloxacin opens a lot of doors in treatment. This is why the stakes go up in terms of safety and monitoring.

Who Should Stay Away

Many folks believe that antibiotics fit everyone, but that isn’t how medicine unfolds. With pefloxacin, the safety concerns speak loudest for children and teenagers. Evidence ties fluoroquinolones to joint pain and cartilage issues in growing bodies. So, most physicians steer away from offering pefloxacin to patients under 18 unless they run out of other choices.

Pregnancy throws even more caution into the mix. Growing evidence hints at risks that could reach the baby, especially with the way bones and joints develop. Mothers who breastfeed pass along drugs through their milk too. That means nursing a baby during pefloxacin treatment could bring potential harm.

People living with a history of tendon disorders or taking steroids also should think twice. Pefloxacin carries a well-known risk of tendon inflammation or rupture. If someone’s ever dealt with a torn Achilles after another quinolone, it doesn’t make sense to roll the dice again. The U.S. FDA adds that warning right up front in its drug safety sheets.

Watch Out for Interactions

Antacids, iron, and multivitamins don’t mix well with pefloxacin. If the stomach’s filled with magnesium or aluminum, less of the antibiotic reaches the bloodstream. That makes it lose its punch. Doctors recommend a gap of at least two hours before or after taking anything that might block absorption.

Beyond that, a person taking medications like theophylline for asthma or caffeine for alertness may notice side effects go up. Pefloxacin might raise the blood levels of these substances, triggering nervousness, tremors, or even convulsions. I knew a patient in my pharmacy days who needed both drugs—she had more trouble sleeping and later had to switch antibiotics after consulting her doctor.

Kidney and Liver Matters

Liver and kidney health plays a big part in how pefloxacin behaves inside the body. Those with chronic liver problems, like cirrhosis or hepatitis, process the drug more slowly. That slow-down can build up dangerous levels, cause confusion, and even seizures. So, doctors frequently check blood values and adjust doses or look for safer alternatives.

The same goes for folks living with kidney troubles. Poor kidney function leads to higher concentrations of the drug. Instead of guessing, a doctor will review lab results and guide the patient safely through treatment.

Takeaways for Safer Treatment

Staying safe with pefloxacin calls for honest conversations. Health workers need to know about joint pain, muscle weakness, or personal family histories of tendon injuries. If someone has seizures or struggles with blood sugar swings, it’s smart to say so. Fluoroquinolones can nudge blood sugar higher or lower, which spells trouble for people with diabetes.

Finally, reporting unexpected aches, swelling, muscle weakness, or mental changes shouldn’t wait until the next appointment. Quick contact with a healthcare provider can prevent serious issues from becoming permanent. In the push against stubborn infections, knowledge protects both patients and doctors alike.

Can Pefloxacin Mesylate interact with other medications?

A Real World Look at Drug Interactions

Few people recognize the risks hiding in their medicine cabinet until trouble pops up. Combining meds sounds straightforward, but the body doesn’t see it that way. Pefloxacin mesylate, a fluoroquinolone antibiotic, gives a strong example. This prescription comes into play for stubborn infections, especially those not giving in to older drugs. It sounds trusted—so plenty of folks expect their doctor or pharmacist to sound an alarm if something won’t mix well. Sadly, a lot can fall through the cracks.

Why Combining Pefloxacin and Other Drugs Demands Caution

I once watched my grandfather struggle with leg pain after starting an antibiotic for a persistent UTI. He never thought to mention his blood thinner or cholesterol pills—after all, why would a little pill for an infection stir up a fuss? Pain kept him up at night, and in a week he landed in the ER. Turns out, that antibiotic—pefloxacin—played a nasty game with his statin and warfarin.

Mixing pefloxacin with blood thinners such as warfarin might bump up the risk of bruising or bleeding. Clinical research shows that fluoroquinolones can interfere with liver enzymes that help clear warfarin. There’s also evidence suggesting these drugs could raise blood levels of other medicines sharing those same metabolic pathways. A 2019 review in the Journal of Antimicrobial Chemotherapy spelled out that up to 1 in 7 hospital antibiotic prescriptions led to unintended drug interactions. That’s not rare.

The Invisible Dangers: Muscle, Nerve, and Heart Trouble

Muscle pain like my grandfather’s isn’t a one-off. Pefloxacin teams up with statins (used for cholesterol) and can stir up the risk of muscle breakdown—a condition called rhabdomyolysis, which turns pee dark and leaves kidneys struggling. If you layer in meds that tax the kidneys, trouble stacks up quickly.

Seizure medications and antidepressants can also spark unintended reactions. I met a patient whose seizure threshold dropped after starting pefloxacin along with her daily anti-epileptic. The antibiotic blocks GABA receptors, easing the brain’s checks on excitement—so patients vulnerable to seizures have reason to speak up before filling that prescription.

Let’s talk the heart, too. Pefloxacin can prolong the QT interval, a fancy way of saying it sometimes messes with the electrical signals keeping your heart’s rhythm regular. Pair it with drugs like amiodarone, sotalol, or even common antipsychotics—that risk shoots even higher. The FDA has flagged cases leading to fainting and irregular beats.

Staying Ahead: What Can Make a Difference

Medication reviews matter. Every physician’s office has stories about patients hurt because nobody caught a risky combo. Pharmacists catch a good portion, but honest conversations at every step work even better. Bring a full list of medicines—herbal and over-the-counter, too—to each appointment. Don’t feel shy about double-checking; most providers like to see engaged patients.

Digital tools chip away at human error. Many health systems run prescriptions through interaction checkers, but the best solutions still depend on clear talk and personal advocacy. The stakes feel highest among older adults juggling several pills or anyone bouncing among multiple specialists. Simple habits—like updating your medication list and watching for early signs such as muscle aches or heart flutters—keep small problems from growing out of control.

Pefloxacin Mesylate
Names
Preferred IUPAC name 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid methanesulfonate
Other names Peflacine
Peflacin
Pronunciation /ˌpiː.flɒkˈsəʊ.sɪn ˈmɛs.ɪ.leɪt/
Identifiers
CAS Number 70458-93-0
Beilstein Reference 85364
ChEBI CHEBI:7863
ChEMBL CHEMBL1447
ChemSpider 16217487
DrugBank DB00609
ECHA InfoCard 03e8e274-7e8a-4c44-870b-8d7ad3c700ac
EC Number 607-428-7
Gmelin Reference 81968
KEGG D05441
MeSH D026110
PubChem CID 656625
RTECS number SY8576000
UNII 0B933500OW
UN number UN2811
Properties
Chemical formula C17H20F2N4O4S
Molar mass 437.49 g/mol
Appearance White or almost white crystalline powder
Odor Odorless
Density 1.48 g/cm3
Solubility in water Soluble in water
log P 0.40
Acidity (pKa) 8.12
Basicity (pKb) 6.28
Magnetic susceptibility (χ) Diamagnetic
Refractive index (nD) 1.62
Dipole moment 3.73 D
Pharmacology
ATC code J01MA03
Hazards
Main hazards Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation.
GHS labelling GHS07, GHS08
Pictograms Health hazard, Exclamation mark
Signal word Warning
Hazard statements Hazard statements: Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation.
Precautionary statements Store in a cool, dry place. Keep out of reach of children. Use only as directed by a physician. Avoid exposure to direct sunlight. Discontinue use if hypersensitivity or adverse reactions occur.
NFPA 704 (fire diamond) Health: 2, Flammability: 0, Instability: 0, Special: -
Flash point 230.2 °C
Lethal dose or concentration LD₅₀ (oral, rat): 3520 mg/kg
LD50 (median dose) LD50 (median dose): Mouse (oral): 2290 mg/kg
NIOSH 83Q6S3BE7A
PEL (Permissible) PEL: Not established
REL (Recommended) 400 mg daily
Related compounds
Related compounds Ciprofloxacin
Norfloxacin
Ofloxacin
Levofloxacin
Enoxacin
Lomefloxacin
Fleroxacin
Gatifloxacin
Moxifloxacin
Sparfloxacin